Abstract:Since the incidence rate of malignant melanoma is increasing annually, development of drugs against melanoma cell metastasis has become more urgent. Luteolin, a naturally occurring flavonoid, is abundant in our daily dietary intake and exhibits a wide spectrum of pharmacological properties. However, the potential anti-cancer role of luteolin in melanoma cells has not been fully investigated. In this study, we have explored whether luteolin inhibits the migration and invasion of A375 human melanoma cells and further elucidated the underlying anti-cancer molecular mechanism of luteolin in melanoma cells. A proliferation assay, flow cytometry and an apoptosis assay were applied to detect the effect of luteolin on the growth and apoptosis of A375 cells. Wound healing assay and transwell invasion assay were used to explore the impact of luteolin on the migration and invasion of A375 cells. Real-time quantitative PCR, western blot and immunofluorescence analysis were used to investigate the effects of luteolin on the expressions of MMP-2, MMP-9 and PI3K/AKT1 in A375 cells. A xenograft tumor animal model was used to investigate the anti-cancer effect of luteolin on the growth of the A375 cells in vivo. Our data indicated that luteolin significantly inhibited the proliferation, migration and invasion of A375 cells and induced the apoptosis of A375 cells in a concentration-dependent manner. Moreover, luteolin reduced the expressions of MMP-2 and MMP-9 and increased the expression of TIMP-1 and TIMP-2. Furthermore, luteolin significantly inhibited the tumor growth of A375 cells in a xenograft mouse model. The immunofluorescence and immunoblotting assays indicated that luteolin inhibited the phosphorylation of AKT1 and PI3K. In conclusion, both in vivo and in vitro studies showed that luteolin inhibited the proliferation and induced the apoptosis of A375 human melanoma cells by reducing the expressions of MMP-2 and MMP-9 through the PI3K/AKT pathway. Overall, luteolin can be considered as a promising anti-cancer agent for the treatment of human melanoma.

The Inhibition of Cell Growth Through the EGFR/ERK/MMP-2 Pathway Induced by Ampelopsin in the Human Malignant Melanoma A375 Cell Line

Ampelopsin induces MDA-MB-231 cell cycle arrest through cyclin B1-mediated PI3K/AKT/mTOR pathway in vitro and in vivo

Inhibition of the growth of human melanoma cells by methionine enkephalin

Effects of Matrine on the Proliferation and Apoptosis Induction in Human Malignant Melanoma Cell Line A375

Ampelopsin Induces Cell Growth Inhibition and Apoptosis in Breast Cancer Cells through ROS Generation and Endoplasmic Reticulum Stress Pathway

Ampelopsin Inhibits Cell Proliferation and Induces Apoptosis in HL60 and K562 Leukemia Cells by Downregulating AKT and NF-κB Signaling Pathways

Inhibitory effect of matrine on the in vitro invasiveness of human malignant melanoma cell line A375

Apigenin Attenuates Melanoma Cell Migration by Inducing Anoikis through Integrin and Focal Adhesion Kinase Inhibition

(S)-(-)-n-[2-(3-hydroxy-2-oxo-2,3-dihydro-1h-indol-3-yl)-ethyl]-acetamide Inhibits Melanoma Cell Growth Through Inducing Apoptosis and Autophagy.

Luteolin inhibits proliferation and induces apoptosis of human melanoma cells in vivo and in vitro by suppressing MMP-2 and MMP-9 through the PI3K/AKT pathway.

Ampelopsin Reduces the Migration and Invasion of Ovarian Cancer Cells Via Inhibition of Epithelial-To-Mesenchymal Transition

Extracts of Centipede Scolopendra Subspinipes Mutilans Induce Cell Cycle Arrest and Apoptosis in A375 Human Melanoma Cells.

Angio-associated Migratory Cell Protein Interacts with Epidermal Growth Factor Receptor and Enhances Proliferation and Drug Resistance in Human Non-Small Cell Lung Cancer Cells.

Oxyfadichalcone C Inhibits Melanoma A375 Cell Proliferation and Metastasis Via Suppressing PI3K/Akt and MAPK/ERK Pathways

Melittin Protein Inhibits the Proliferation of MG63 Cells by Activating Inositol-Requiring Protein-1Α and X-box Binding Protein 1-Mediated Apoptosis.

Inhibition of Invasion and Up-Regulation of E-cadherin Expression in Human Malignant Melanoma Cell Line A375 by (-)-Epigallocatechin-3-gallate

Berberine Inhibits Human Melanoma A375.S2 Cell Migration And Invasion Via Affecting The Fak, Upa, And Nf-Kappa B Signaling Pathways And Inhibits Plx4032 Resistant A375.S2 Cell Migration In Vitro

Berberine Inhibits Human Melanoma A375.S2 Cell Migration and Invasion via Affecting the FAK, uPA, and NF-κB Signaling Pathways and Inhibits PLX4032 Resistant A375.S2 Cell Migration In Vitro

Ailanthone Induces Cell Cycle Arrest and Apoptosis in Melanoma B16 and A375 Cells

AMPK Activation by GSK621 Inhibits Human Melanoma Cells in Vitro and in Vivo.

Comparative Evaluation of Anticancer Activity of Natural Methoxylated Flavones Xanthomicrol and Eupatilin in A375 Skin Melanoma Cells